2021
Interstage mortality in two‐stage elephant trunk surgery
Saeyeldin A, Gryaznov AA, Zafar MA, Wu J, Mukherjee S, Vallabhajosyula P, Ziganshin BA, Elefteriades JA. Interstage mortality in two‐stage elephant trunk surgery. Journal Of Cardiac Surgery 2021, 36: 1882-1891. PMID: 33634489, DOI: 10.1111/jocs.15441.Peer-Reviewed Original ResearchConceptsExtensive thoracic aortic aneurysmThoracic aortic aneurysmInterstage intervalStage IIET procedureStage II procedureHospital mortalityInterstage mortalityMega aortaTrunk surgeryAortic ruptureOverall mortalitySingle surgeonAortic diseasePatient groupAortic aneurysmPatientsStage IMortalityCumulative mortalityI procedureInterval periodRupturePrior studiesSafetyIs Aortic Z-score an Appropriate Index of Beneficial Drug Effect in Clinical Trials in Aortic Aneurysm Disease?
Elkinany S, Weismann C, Curtis A, Smith T, Zafar MA, Breen T, Li Y, Tranquilli M, Rizzo JA, Mukherjee SK, Ziganshin BA, Elefteriades JA. Is Aortic Z-score an Appropriate Index of Beneficial Drug Effect in Clinical Trials in Aortic Aneurysm Disease? The American Journal Of Cardiology 2021, 143: 145-153. PMID: 33352210, DOI: 10.1016/j.amjcard.2020.12.025.Peer-Reviewed Original ResearchConceptsBody mass indexAortic Z-scoresZ-score decreaseBeneficial drug effectsZ-scoreMarfan patientsClinical trialsAneurysm diseaseDrug effectsChild's ageEcho examAortic dilation rateDecreased Z-scoreConnective tissue diseaseBody surface areaEffects of medicationAortic aneurysm diseaseClinical drug trialsMass indexTissue diseaseAortic diseaseAneurysmal pathologyDrug trialsInvestigational drugsSpontaneous decrease
2017
Medical management of aortic disease in Marfan syndrome.
Bin Mahmood SU, Velasquez CA, Zafar MA, Saeyeldin AA, Brownstein AJ, Ziganshin BA, Elefteriades JA, Mukherjee SK. Medical management of aortic disease in Marfan syndrome. Annals Of Cardiothoracic Surgery 2017, 6: 654-661. PMID: 29270377, PMCID: PMC5721117, DOI: 10.21037/acs.2017.11.09.Peer-Reviewed Original ResearchAngiotensin receptor blockersMedical managementMarfan syndromeMFS patientsThoracic aortic aneurysm diseaseDifferent medical regimensStandard of careAortic aneurysm diseaseNumerous pathophysiological effectsAortic dilatationReceptor blockersAortic diseaseMedical regimensCurrent guidelinesAneurysm diseaseCardiovascular organsΒ-blockersCurrent evidencePathophysiological effectsHereditary disorderPatientsSyndromeDiseaseRegimensManagement
2013
Medical Treatment for Thoracic Aortic Aneurysm – Much More Work To Be Done
Chun AS, Elefteriades JA, Mukherjee SK. Medical Treatment for Thoracic Aortic Aneurysm – Much More Work To Be Done. Progress In Cardiovascular Diseases 2013, 56: 103-108. PMID: 23993243, DOI: 10.1016/j.pcad.2013.05.008.Peer-Reviewed Original ResearchConceptsReceptor blockersAortic diseaseAortic aneurysmMedical treatmentBeta-adrenergic receptor blockersAngiotensin receptor blockersAortic aneurysm repairForms of pharmacotherapyThoracic aortic diseaseThoracic aortic aneurysmMatrix metalloproteinase inhibitorsAortic surgeryAortic expansionAneurysm repairAortic ruptureMedical therapySurgical repairSurgical interventionAortic riskAortic valveGuideline criteriaMaximal diameterMetalloproteinase inhibitorsFuture riskAneurysmsDo β-Blockers Really Work for Prevention of Aortic Aneurysms?
Chun AS, Elefteriades JA, Mukherjee SK. Do β-Blockers Really Work for Prevention of Aortic Aneurysms? Aorta 2013, 01: 45-51. PMID: 26798671, PMCID: PMC4682697, DOI: 10.12945/j.aorta.2013.13.002.Peer-Reviewed Original ResearchΒ-blockade therapyΒ-blocker treatmentAortic aneurysmMarfan syndromeClinical trialsMulticenter clinical trialSeparate clinical trialsScientific evidenceAdrenergic-blocking drugsAortic aneurysm growthAortic diseaseConventional therapyΒ-blockersGeneral populationPatientsAneurysmsSyndromeAneurysm growthTherapyTrialsTreatmentLiterature reviewDiseaseProgressionPrevention